Temozolomide in Treating Patients With Progressive Low-Grade Glioma
Completed · Phase 2
Conditions studied: Brain and Central Nervous System Tumors
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well temozolomide works in treating patients with progressive low-grade glioma.
Key facts
- Study ID
- NCT00003466
- Run by
- Duke University
- People needed
- 100
- Starts
- 1998-03-01
- Expected to finish
- 2005-07-01
- Last updated by the study team
- 2014-07-09
Who can join
Age: 4 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Duke Comprehensive Cancer Center — Durham, North Carolina, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.